REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
Sponsored by Medtronic Neurovascular Clinical Affairs
About this study
Post-Market Registry
An observational, prospective, multi-center, single-arm registry to provide continuing evaluation of safety and effectiveness of Medtronic Neurovascular commercially available products used in the treatment of acute ischemic stroke.
Where this study is enrolling (3)
- I'm interested
McLaren Flint Hospital
Flint, Michigan
- I'm interested
Buffalo General Medical Center
Buffalo, New York
- I'm interested
University of Texas Health Science Center at Houston
Houston, Texas
Who can participate
Inclusion criteria
- ✓1. Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
- ✓2. Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device\* during treatment for acute ischemic stroke.
- ✓3. Participant is 18 years of age or older.
Exclusion criteria
- ✕1. Participant who may be unable to complete follow-up within the registry.
- ✕2. Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
- ✕3. Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.